COMMUNIQUÉS West-GlobeNewswire

Foamix Announces Enrollment of First Patient in Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam
19/09/2019
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), today announced that the first patient has been enrolled in its Phase 2 clinical trial to evaluate the [...]
MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement
19/09/2019
MediPharm to produce high-quality cannabis concentrate filled vapes for Cronos Group Deal reinforces MediPharm Labs’ leadership in large scale manufacturing and distribution TORONTO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- [...]
Strongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology
19/09/2019
~ RECORLEV Resulted in Sustained Improvements in Urinary Free Cortisol (UFC) and Provided Clinical Benefit, As Demonstrated By Improvements in Comorbidities and Characteristic Signs and Symptoms of Cushing’s Syndrome [...]
T2 Biosystems Reports Granting of Inducement Awards
19/09/2019
LEXINGTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare [...]
Theratechnologies Reaches Agreement With AIDS Drug Assistance Program (ADAP) for New EGRIFTA SV™
19/09/2019
Agreement for Trogarzo® renewed MONTREAL, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) is pleased to announce that an agreement has been reached with the AIDS Drug Assistance Program Crisis Task [...]
Theratechnologies conclut une entente avec le AIDS Drug Assistance Program (ADAP) pour le nouveau EGRIFTA SV(MC)
19/09/2019
L’entente pour Trogarzo(MD) est renouvelée MONTRÉAL, 19 sept. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (TSX: TH) est heureuse d’annoncer qu’une entente a été conclue avec le groupe de travail du AIDS Drug [...]
CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK
19/09/2019
Company strengthens market presence in United Kingdom with licensing of Electronic Data Capture Technology in partnership with UK-based MyAccess Clinics MyAccess Clinics to use CB2’s software within multi-clinic [...]
CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business.
19/09/2019
CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business. Switzerland – 19 September 2019 CryoSave has since its establishment in 2000, ensured [...]
Clearside Biomedical Featured at Multiple European Scientific Retinal Congresses
19/09/2019
ALPHARETTA, Ga., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people [...]
The Joint Corp. to Present at the 5th Annual B. Riley FBR Consumer & Media Conference
19/09/2019
SCOTTSDALE, Ariz., Sept. 19, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will present at the 5 th Annual B. Riley FBR [...]
Axogen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
19/09/2019
ALACHUA, Fla., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced [...]
Microbix Quality Products Enter U.S. Market
19/09/2019
Four IVD Controls to Support Performance of Human Papilloma Virus (HPV) Tests MISSISSAUGA, Ontario, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products [...]
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma
19/09/2019
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting [...]
ASLAN Pharmaceuticals Presents Late-Breaking Data From Phase 2 Study in China Testing Varlitinib in Second Line Biliary Tract Cancer at CSCO
19/09/2019
- Biliary tract cancer (BTC) patients treated with varlitinib plus capecitabine in second line achieved a response rate of 11% including two complete responses, median PFS of 2.7 months and OS of 5.8 months - Patients [...]
AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1
19/09/2019
New interim data from SPR1NT study supports critical importance of early intervention in pre-symptomatic SMA patients, leading to age‑appropriate major milestone gain Updated results from global STR1VE study demonstrate [...]
Inventiva completes a capital increase of € 8.2 million subscribed by leading US and European biotech investors
19/09/2019
New financing will enable the Company to extend from Q2 2020 to the end of Q3 2020 its cash runway beyond the ongoing lanifibranor and odiparcil clinical study results Capital raised at the closing price of 18 September [...]
Inventiva réalise une augmentation de capital de 8,2 millions d'euros souscrite par des investisseurs américains et européens de premier plan dans le secteur des biotechnologies
19/09/2019
Un nouveau financement permettant à la Société d'étendre sa visibilité financière du 2 ème trimestre 2020 jusqu'à la fin du 3 ème trimestre 2020 au-delà des résultats des études cliniques en cours sur lanifibranor et [...]
Annual Financial Report
19/09/2019
DXS INTERNATIONAL PLC ANNUAL RESULTS for the year ended 30 April 2019 The Board of DXS International plc (“the Company”), the NEX Growth Market quoted healthcare information and digital clinical decision support systems [...]
Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory Society International Congress 2019
19/09/2019
LONDON, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, announces that it will present positive interim data [...]

Pages